Provide various narc medication for the inmate population at FCC oakdale for FY26.
Ended Awarded Last action
- Contract number
- 15B51826F00000008
- Awardee
-
Mckesson Corporation UEI S1RUKWWRYFL6 Part of Mckesson Corporation
- Awarding agency
-
Federal Correctional Complex Oakdale
Correctional Facilities, Department of Justice
- Obligated
- $20,720
Award facts
- Contract value 100% obligated
- $20,719.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irving, TX 75039, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $20,000 | |
| Other Administrative Action | $300 | |
| Funding Only Action | $150 | |
| Funding Only Action | $100 | |
| Original award | $170 |
About this award
McKesson Corporation received a delivery order valued at $20,719.78 from the Federal Correctional Complex Oakdale to provide narcotic medications for the inmate population during Fiscal Year 2026. The award, issued on December 3, 2025, represents an increase of $20,000 to the original delivery order amount and is structured as a firm fixed price contract with an ultimate completion date of August 9, 2026. This delivery order was issued without a set-aside designation, reflecting McKesson's established competitive position as a large business contractor. The work will be performed from McKesson's Irving, Texas location, where the company maintains its pharmaceutical distribution infrastructure supporting federal healthcare operations.
This delivery order falls under McKesson's existing federal contract vehicle supporting pharmaceutical procurement for multiple Bureau of Prisons facilities. The company maintains a substantial history of supplying controlled and non-controlled medications to correctional institutions nationwide, including Federal Correctional Institutions, Federal Correctional Complexes, and U.S. Penitentiaries. McKesson's extensive engagement with the Federal Bureau of Prisons reflects its critical role as a pharmaceutical supplier to the federal correctional healthcare system, with delivery orders issued throughout the year to ensure reliable access to essential medications supporting inmate healthcare operations across the agency's nationwide network of facilities.
Quick answers
Who was awarded contract 15B51826F00000008?
15B51826F00000008 was awarded to Mckesson Corporation by Federal Correctional Complex Oakdale (Correctional Facilities) on December 3, 2025.
How much is contract 15B51826F00000008 worth?
The government has obligated $20,720 on 15B51826F00000008.
Is contract 15B51826F00000008 an order under another contract?
Yes. 15B51826F00000008 is a delivery order under 36W79720D0001, an indefinite delivery contract.
Was contract 15B51826F00000008 competed?
The extent of competition for 15B51826F00000008 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award